Open Topic Search

Reset

NOTE: The Solicitations and topics listed on this site are copies from the various SBIR agency solicitations and are not necessarily the latest and most up-to-date. For this reason, you should visit the respective agency SBIR sites to read the official version of the solicitations and download the appropriate forms and rules.

If no search results for your keyword(s) were found, you are encouraged to review Agency omnibus solicitations for additional funding opportunities. Omnibus solicitations are structured to be broad, extensive Programmatic issuances with research areas related to the petitioning Agency and are not limited to predetermined Topics/Subtopics. If upon reviewing you have additional questions, you may consider reaching out to the respective Agency for clarification regarding acceptable proposals (https://www.sbir.gov/agency-contacts).

Displaying 1 - 10 of 74 results
  1. PAR-17-300: NeuroNEXT Small Business Innovation in Clinical Trials (U44)

    Release Date: 06-05-2017Open Date: 08-05-2017 Due Dates: Multiple Close Date: 01-05-2018

    Purpose: To facilitate the cooperation and partnering of public and private funding organizations, universities, academic medical centers, research institutes, contract research organizations, biotechnology companies, and pharmaceutical companies, NINDS has formed the Neurology Network of Excellence in Clinical Trials (NeuroNEXT, www.NeuroNEXT.org). NeuroNEXT has a Clinical Coordinating Center (CC ...

    SBIR Department of Health and Human Services
  2. PA-17-302 : PHS 2017-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])

    Release Date: 06-05-2017Open Date: 08-05-2017 Due Dates: Multiple Close Date: 01-05-2018

    The SBIR program, as established by law, is intended to meet the following goals: stimulate technological innovation in the private sector; strengthen the role of small business in meeting Federal research or research and development (R/R&D) needs; increase the commercial application of Federally-supported research results; foster and encourage participation by socially and economically disadv ...

    SBIR Department of Health and Human Services
  3. PA-17-303 : PHS 2017-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])

    Release Date: 06-05-2017Open Date: 08-05-2017 Due Dates: Multiple Close Date: 01-05-2018

    Recommended length: 1-5 pages. Present the purpose of the funding opportunity in paragraph form, addressing all of the items below. Please keep in mind that readers will appreciate clarity and brevity. The following headers may be useful in preparing this section: Purpose/Research objectives (describe the nature and need of the research opportunity) Specific Areas of Research Interest (include e ...

    STTR Department of Health and Human Services
  4. RFA-ES-17-004 : SBIR E-learning for HAZMAT and Emergency Response (R43/R44)

    Release Date: 05-15-2017Open Date: 06-28-2017Due Date: 07-28-2017Close Date: 07-28-2017

    This SBIR FOA focuses on the development of e-learning training products that assist both students and instructors with a variety of delivery platforms. Note that all products must be directly related to the health and safety training of workers exposed to hazardous (HAZMAT) materials such as chemical, biological, or radiological substances. Occupations that encompass workers exposed to these haza ...

    SBIR Department of Health and Human Services
  5. RFA-DA-17-010 : Wearable to Track Recovery and Relapse Factors for People w/ Addiction (R43/R44)

    Release Date: 05-12-2017Open Date: 07-15-2017Due Date: 08-15-2017Close Date: 08-15-2017

    Background Currently there is no cost effective tool which enables researchers to study drug addiction relapse in real time. The standard remains to be urine analysis or self-report/surveys. Unfortunately, depending on the drug, urine analysis can only detect recent drug use in the previous 24 to 72 hours. Even in the best case scenario and based on lab assay results, the associated intervention r ...

    SBIR Department of Health and Human Services
  6. PAR-17-275 : NIH StrokeNet Small Business Innovation Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U44)

    Release Date: 05-10-2017Open Date: 08-05-2017 Due Dates: Multiple Close Date: 01-05-2018

    Purpose To facilitate the cooperation and partnering of public and private funding organizations, universities, academic medical centers, research institutes, contract research organizations, biotechnology companies, and pharmaceutical companies in the advancement of interventions for stroke prevention, treatment, and rehabilitation, NINDS has formed the NIH Stroke Clinical Trials Research Network ...

    SBIR Department of Health and Human Services
  7. RFA-DA-18-007 : Nasal Delivery of CNS Therapeutics (R41/R42)

    Release Date: 04-25-2017Open Date: 07-24-2017Due Date: 08-23-2017Close Date: 08-23-2017

    Section I. Funding Opportunity Description    Less than 2% of small molecule pharmacotherapeutics effectively cross the blood brain barrier (BBB) . Larger molecules, such as peptides or antibodies, are virtually impenetrable. Direct routes of administration (e.g., epidural-, intracerebral- or intracerebral ventricular delivery) are invasive, costly and impractical for repeated dosing int ...

    STTR Department of Health and Human Services
  8. RFA-DA-18-006 : Nasal Delivery of CNS Therapeutics (R43/R44)

    Release Date: 04-25-2017Open Date: 07-24-2017Due Date: 08-23-2017Close Date: 08-23-2017

    Section I. Funding Opportunity Description  Less than 2% of small molecule pharmacotherapeutics effectively cross the blood brain barrier (BBB). Larger molecules, such as peptides or antibodies, are virtually impenetrable. Direct routes of administration (e.g., epidural-, intracerebral- or intracerebral ventricular delivery) are invasive, costly and impractical for repeated dosing into the CN ...

    SBIR Department of Health and Human Services
  9. RFA-HD-18-028 : Point of Care Technologies for the Evaluation and Management of Obstetrics, Neonatal, and Pediatric Critical Care Patients, and for Patients with Disorders of Reproductive Tract and Infertility (R43/R44)

    Release Date: 04-13-2017Open Date: 05-30-2017Due Date: 06-30-2017Close Date: 06-30-2017

    Background Many medical conditions in obstetrics, neonatology, pediatric critical care, reproductive endocrinology and infertility involve clinical states that evolve or change over short time frames.  For example, critically ill neonatal and pediatric patients are particularly fragile needing careful monitoring of their diseases processes, fine-tuning of their care based on laboratory findin ...

    SBIR Department of Health and Human Services
  10. RFA-CA-17-024 : SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization (R44)

    Release Date: 04-12-2017Open Date: 06-06-2017Due Date: 07-06-2017Close Date: 07-06-2017

    Purpose The Small Business Innovation Research (SBIR) Program is an important mechanism by which the National Institutes of Health (NIH) and other Federal agencies help bring innovative solutions to public health challenges. A major objective of the Federal SBIR Program is to facilitate the commercialization of technologies developed by small business concerns (SBCs). Yet, the development of medic ...

    SBIR Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government